In this issue:
RS3PE appears to be a distinct entity of RA
IL-1 pathways: a limited role in RA
TNF inhibitors in RA: no increase in mortality
Sequential TNF-α inhibitor treatment in RA
Rescue treatment strategies in Wegener’s granulomatosis and microscopic polyangiitis
ASQoL valid for NZ patients with axial spondyloarthritis
Use scMTX after oral MTX in a tight control strategy?
Prevalence of pulmonary hypertension in SSc
Umbilical cord mesenchymal stem cells for RA?
Please login below to download this issue (PDF)